A dynamic decision support tool for use in the design of bio-manufacturing facilities and processes
暂无分享,去创建一个
[1] Rafiqul Gani,et al. Process synthesis and simulation strategies for integrated biochemical process design , 1996 .
[2] Rachel Legmann,et al. A predictive high‐throughput scale‐down model of monoclonal antibody production in CHO cells , 2009, Biotechnology and bioengineering.
[3] J. Carson. Introduction to modeling and simulation , 2005, Proceedings of the Winter Simulation Conference, 2005..
[4] W. Velicer,et al. Comparison of five rules for determining the number of components to retain. , 1986 .
[5] Duncan Low,et al. Future of antibody purification. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[6] Gail Sofer. Regulatory Trends Related to Process Validation , 2000 .
[7] N J Titchener-Hooker,et al. Economic comparison between conventional and disposables-based technology for the production of biopharmaceuticals. , 2001, Biotechnology and bioengineering.
[8] Joe X. Zhou,et al. Viral clearance using disposable systems in monoclonal antibody commercial downstream processing , 2008, Biotechnology and bioengineering.
[9] Jeremy S. Conner,et al. Application of Multivariate Analysis toward Biotech Processes: Case Study of a Cell‐Culture Unit Operation , 2007, Biotechnology progress.
[10] Martyn S. Ray,et al. Coulson and Richardson's Chemical Engineering Volume 6 (Design), 2nd Edition, by R.K. Sinnott, Pergamon Press, Oxford, UK (1993). 954 pages. ISBN 0‐08‐041865‐1. , 2008 .
[11] R. Rummel. Applied Factor Analysis , 1970 .
[12] Anu Maria,et al. Introduction to modeling and simulation , 1997, WSC '97.
[13] N. Thornhill,et al. Multidimensional Visualization and Clustering of Historical Process Data , 2006 .
[14] Ray Farmer,et al. Object-Oriented Systems Analysis and Design Using UML , 2001 .
[15] P Dunnill,et al. Prediction of the pilot-scale recovery of a recombinant yeast enzyme using integrated models. , 2001, Biotechnology and bioengineering.
[16] Averill M. Law,et al. Selecting simulation software for manufacturing applications , 1989, WSC '89.
[17] Sunil Chhatre,et al. Ultra scale‐down approach to correct dispersive and retentive effects in small‐scale columns when predicting larger scale elution profiles , 2009, Biotechnology progress.
[18] R. Cattell. The Scree Test For The Number Of Factors. , 1966, Multivariate behavioral research.
[19] Suzanne S. Farid,et al. Modelling of the biopharmaceutical drug development pathway and portfolio management , 2005, Comput. Chem. Eng..
[20] T Shanklin,et al. Selection of bioprocess simulation software for industrial applications. , 2001, Biotechnology and bioengineering.
[21] Suzanne S Farid,et al. Decision‐Support Tool for Assessing Biomanufacturing Strategies under Uncertainty: Stainless Steel versus Disposable Equipment for Clinical Trial Material Preparation , 2008, Biotechnology progress.
[22] S. Hober,et al. Protein A chromatography for antibody purification. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[23] M. E. Pate,et al. Principal Component Analysis of Nonlinear Chromatography , 2008, Biotechnology progress.
[24] Gail Soler,et al. Regulatory Trends Related to Process Validation , 2000 .
[25] Kurt Brorson,et al. Generic/matrix evaluation of SV40 clearance by anion exchange chromatography in flow‐through mode , 2003, Biotechnology and bioengineering.
[26] Jeff Davis,et al. Use of Process Data To Assess Chromatographic Performance in Production‐Scale Protein Purification Columns , 2003, Biotechnology progress.
[27] G. Hale,et al. Repeated cleaning of protein A affinity column with sodium hydroxide. , 1994, Journal of immunological methods.
[28] M. Kamarck,et al. Building biomanufacturing capacity—the chapter and verse , 2006, Nature Biotechnology.
[29] Yuhong Zhou,et al. A decisional-support tool to model the impact of regulatory compliance activities in the biomanufacturing industry , 2004, Comput. Chem. Eng..
[30] J. Edward Jackson,et al. A User's Guide to Principal Components. , 1991 .
[31] Sunil Chhatre,et al. The Integrated Simulation and Assessment of the Impacts of Process Change in Biotherapeutic Antibody Production , 2006, Biotechnology progress.
[32] S Karri,et al. A Tool for Modeling Strategic Decisions in Cell Culture Manufacturing , 2000, Biotechnology progress.
[33] S. Qin,et al. Selection of the Number of Principal Components: The Variance of the Reconstruction Error Criterion with a Comparison to Other Methods† , 1999 .
[34] Rolf Danielsson,et al. Alignment of chromatographic profiles for principal component analysis: a prerequisite for fingerprinting methods , 1994 .
[35] Jochen Strube,et al. Challenges in biotechnology production—generic processes and process optimization for monoclonal antibodies , 2005 .
[36] S Gülich. Protein engineering of an IgG-binding domain allows milder elution conditions during affinity chromatography , 2000 .
[37] J. J. Stewart,et al. Putting a price on biotechnology , 2001, Nature Biotechnology.
[38] E. Keshavarz-Moore,et al. A decision-support model for evaluating changes in biopharmaceutical manufacturing processes , 2007, Bioprocess and biosystems engineering.
[39] Brian Hubbard,et al. Downstream processing of monoclonal antibodies--application of platform approaches. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[40] Suzanne S. Farid,et al. Modelling biopharmaceutical manufacture: Design and implementation of SimBiopharma , 2007, Comput. Chem. Eng..
[41] Miriam Monge,et al. Biomanufacturing for the 21 st Century Designing a Concept Facility Based on Single-Use Systems , 2004 .
[42] Patrick Thompson,et al. Defining process design space for monoclonal antibody cell culture , 2010, Biotechnology and bioengineering.
[43] D. Krahl,et al. The Extend simulation environment , 2000, Proceeding of the 2001 Winter Simulation Conference (Cat. No.01CH37304).
[44] Wei Wang,et al. Protein aggregation and its inhibition in biopharmaceutics. , 2005, International journal of pharmaceutics.
[45] David J Roush,et al. Maximizing productivity of chromatography steps for purification of monoclonal antibodies , 2008, Biotechnology and bioengineering.
[46] Suzanne S Farid,et al. Fed‐batch and perfusion culture processes: Economic, environmental, and operational feasibility under uncertainty , 2013, Biotechnology and bioengineering.
[47] Suzanne S Farid,et al. A computer‐aided approach to compare the production economics of fed‐batch and perfusion culture under uncertainty , 2006, Biotechnology and bioengineering.
[48] D. Bracewell,et al. Principal Component Score Modeling for the Rapid Description of Chromatographic Separations , 2008, Biotechnology progress.
[49] Ian Gosling. Process simulation and modeling for industrial bioprocessing: Tools and techniques , 2005 .
[50] X. Wang,et al. Multidimensional Visualization of Principal Component Scores for Process Historical Data Analysis , 2004 .
[51] M E Groep,et al. Performance modeling and simulation of biochemical process sequences with interacting unit operations. , 2000, Biotechnology and bioengineering.
[52] David W. Embley,et al. Object-oriented systems analysis , 1992 .
[53] E. Boschetti,et al. Composite affinity sorbents and their cleaning in place. , 1990, Journal of chromatography.
[54] J. Bonnerjea,et al. Scale-up of monoclonal antibody purification processes. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[55] John S. Carson,et al. Modeling and simulation worldviews , 1993, WSC '93.
[56] K E Willard,et al. Probabilistic Analysis of Decision Trees Using Monte Carlo Simulation , 1986, Medical decision making : an international journal of the Society for Medical Decision Making.
[57] Eric N M van Sprang,et al. Multivariate data analysis on historical IPV production data for better process understanding and future improvements , 2010, Biotechnology and bioengineering.
[58] Ashraf Amanullah,et al. Novel micro‐bioreactor high throughput technology for cell culture process development: Reproducibility and scalability assessment of fed‐batch CHO cultures , 2010, Biotechnology and bioengineering.
[59] Suzanne S Farid,et al. Strategic Biopharmaceutical Portfolio Development: An Analysis of Constraint‐Induced Implications , 2008, Biotechnology progress.
[60] Suzanne S Farid,et al. Combining Multiple Quantitative and Qualitative Goals When Assessing Biomanufacturing Strategies under Uncertainty , 2008, Biotechnology progress.
[61] Anurag S Rathore,et al. Application of near‐infrared (NIR) spectroscopy for screening of raw materials used in the cell culture medium for the production of a recombinant therapeutic protein , 2009, Biotechnology progress.
[62] R. W. Rozett,et al. Methods of factor analysis of mass spectra , 1975 .
[63] A. Arunakumari,et al. Advances in Non-Protein A Purification Processes for Human Monoclonal Antibodies : In three non-affinity purification processes based on cation exchange capture with high binding capacity, applying a host cell protein exclusion strategy enabled robust scale up and better economics , 2009 .
[64] Nigel J. Titchener-Hooker,et al. A framework for assessing the solutions in chromatographic process design and operation for large-scale manufacture , 2006 .
[65] Yuhong Zhou,et al. Application of a Decision‐Support Tool to Assess Pooling Strategies in Perfusion Culture Processes under Uncertainty , 2008, Biotechnology progress.
[66] Kurt Brorson,et al. Bracketed generic inactivation of rodent retroviruses by low pH treatment for monoclonal antibodies and recombinant proteins. , 2003, Biotechnology and bioengineering.
[67] K. Gernaey,et al. Good modeling practice for PAT applications: Propagation of input uncertainty and sensitivity analysis , 2009, Biotechnology progress.
[68] M Vanderlaan,et al. Industrial Purification of Pharmaceutical Antibodies: Development, Operation, and Validation of Chromatography Processes , 2001, Biotechnology & genetic engineering reviews.
[69] F. Steindl,et al. Comparison of protein A affinity sorbents III. Life time study. , 2006, Journal of chromatography. A.
[70] Mark Teeters,et al. Predicting diafiltration solution compositions for final ultrafiltration/diafiltration steps of monoclonal antibodies , 2011, Biotechnology and bioengineering.
[71] Paul J. Mcdonald,et al. Fragments of protein A eluted during protein A affinity chromatography. , 2007, Journal of chromatography. A.
[72] Brian Kelley,et al. Very Large Scale Monoclonal Antibody Purification: The Case for Conventional Unit Operations , 2007, Biotechnology progress.
[73] Seongkyu Yoon,et al. Estimation of raw material performance in mammalian cell culture using near infrared spectra combined with chemometrics approaches , 2012, Biotechnology progress.
[74] Steven M Cramer,et al. Improved process analytical technology for protein a chromatography using predictive principal component analysis tools , 2011, Biotechnology and bioengineering.